The neuropathology of HIV infection in the era of highly active antiretroviral therapy;La pathologie du système nerveux central líée au VIH à l'ère des multithérapies

Annales de Pathologie

Volumn 23, Issue 5, 2003, Pages 408-423

  Vallat Decouvelaere, Anne Valérie ^a   Chrétien, Fabrice ^b   Lorin De La Grandmaison, Geoffroy ^c   Carlier, Robert ^c   Force, Gilles ^d   Gray, Françoise ^c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c RAYMOND POINCARÉ HOSPITAL   (France)

^d Centre Medical Fernand Bezancon   (France)

Author keywords

AIDS; Central nervous system; HAART; HIV; Neuropathology

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOPSY; BRAIN LYMPHOMA; CAUSE OF DEATH; CELL INFILTRATION; CYTOMEGALOVIRUS; DISEASE COURSE; FRANCE; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS; HERPES ZOSTER ENCEPHALITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INCIDENCE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; NEUROPATHOLOGY; NONHODGKIN LYMPHOMA; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; SURVIVAL; TOXOPLASMOSIS; VARICELLA ZOSTER VIRUS; VIRUS ENCEPHALITIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; AUTOPSY; BRAIN; CAUSE OF DEATH; HIV INFECTIONS; HUMANS; NERVOUS SYSTEM; RETROSPECTIVE STUDIES;

EID: 0347990684     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Barré-Sinoussi F, Cherman JC, Rey F, Nugeyre MT, Chamaret S, Gruest J et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220: 868-71.
2. Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation and continuous production of cytopathic retroviruses (HT_V-111) from patients with AIDS and pre-AIDS. Science 1984; 224: 497-500.
3. Budka H, Wiley CA, Kleihues P, Artigas J, Asbury AK, Cho E-S et al. HIV-related disease of the nervous system: A glossary and proposal for neuropathology-based terminology. Brain Pathol 1991; 1: 143-50.
4. Gray F. Atlas of the Neuropathology of HIV infection. Oxford New York Tokyo, Oxford University press, 1993.
5. Gray F, Adle-Biassette H, Brion F, Ereau T, Le Maner I, Levy V et al. Neuronal apoptosis in human immunodeficiency virus infection. J Neuro Virol 2000; 6: S38-S43.
6. Gray F, Adle-Biassette H, Chrétien F, Lorin de la Grandmaison G, Force G, Keohane C. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Clin Neuropathol 2001; 20: 145-55.
7. Price RW, Sitdis JJ, Brew BJ. AIDS dementia complex and HIV-1 infection: A view from the clinic. Brain Pathol 1991; 1: 155-62.
8. Gray F, Chrétien F, Decouvelaere AV, Adle-Biassette H. Pathogenesis of HIV-induced lesions of the brain and correlation with HIV-associated cognitive disorders. Histopathology 2002; 41: 32-6.
9. Gray F, Geny C, Dournon E, Fénelon G, Lionnet F, Gherardi R. Neuropathological evidence that zidovudine reduces incidence of HIV infection of brain (letter). Lancet 1991; 337: 852-3.
10. Dorenbaum A, Cunningham CK, Gelber RD Culnane M, Mofenson L, Britto P et al. Two dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA 2002; 288: 189-98.
11. Hogg R S, O'Shaughnessy M V, Gataric N, Yip B, Craib K, Schechter MT et al. Decline in deaths from AIDS due to new antiretrovirals. Lancet 1997; 349: 1294.
12. Bonnet F, Morlat P, Chene G, Mercie P, Neau D, Chossat I et al. Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999. HIV Med 2002; 3: 195-9.
13. D'Arminio Monforte A, Duca PG, Vago L, Grassi MP, Moroni M. Decreasing incidence of CNS AIDS defining events associated with antiretroviral therapy. Neurology 2000; 54: 1856-9.
14. Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry 2000; 69: 376-80.
15. Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, Autran B. Long-lasting recovery in CD4 T-cell function and viral load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998; 351: 1682-6.
16. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN et al. HIV associated neurologic disease incidence changes: Multicenter AIDS cohort study, 1990-1998. Neurology 2001; 56: 257-60.
17. Hoffmann C, Tabrizian S, Wolf E, Eggers C, Stoehr A, Plettenberg A et al. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 2001; 15: 2119-27.
18. Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Mertenskotter T et al. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 1998; 12: 1149-54.
19. Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ et al. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 1999; 52: 623-5.
20. Gasnault J, Taoufik Y, Goujard C, Kousignian P, Abbed K, Boue F et al. Prolonged survival without neurological impairment in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy. J Neurovirol 1999; 5: 241-9.
21. Sacktor NC, Lyles RH, Skolasky RL, Kleeberger C, Selnes OA, Miller EN et al. Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS). Neurology 1999; 52: 1640-7.
22. Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC. Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. J Neurovirol 2000; 6: 84-8.
23. Chang L, Ernst T, Leonido-Yee M, Witt M, Speck O, Walot I et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 1999; 53: 782-9.
24. Dore G, Correll PK, Ly, Y, Kaldor JM, Cooper D.A, Brew BJ. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 1999; 13: 1249-53.
25. Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 2002; 8: 136-42.
26. Tozzi V, Balestra P, Galgani S, Narciso P, Sampaolesi A, Antinori A et al. Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years. J Acquir Immune Defic Syndr 2001; 28: 19-27.
27. Jellinger KA, Setinek U, Drlicek M, Böhm G, Steurer A, Lintrier F. Neuropathology and general autopsy findings in AIDS during the last years. Acta Neuropathol 2000; 100: 213-20.
28. Masliah E, DeTeresa RM, Mallory ME, Hansen LA. Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 2000; 14: 69-74.
29. Morgello S, Mahboob R, Yakoushina T, Khan S, Hague K. Autopsy findings in human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors and time. Arch Pathol Lab Med 2002; 126: 182-90.
30. Ammassari A, Cingolani A, Pezzotti P, De Luca A, Murri R, Giancola ML et al. AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology 2000; 55: 1194-200.
31. Gray F, Geny C, Lionnet F, Doumon E, Fénelon G, Gherardi R, Poirier J. Étude neuropathologique de 135 cas adultes de syndrome d'immunodéficience acquise (SIDA). Ann Pathol 1991; 11: 236-47.
32. Gray F, Gherardi R, Keohane C, Favolini M, Sobel A, Poirier J. Pathology of the Central Nervous System in 40 cases of Acquired Immune Deficiency Syndrome (AIDS). Neuropathol Applied Neurol 1988; 14: 365-80.
33. Gray F, Chrétien F, Vallat-Decouvelaere AV, Scaravilli F. The changing pattern of HIV Neuropathology in the HAART era. J Neuropathol Exp Neurol 2003; 62: 429-40.
34. O'Sullivan CE, Drew WL, McMullen DJ, Miner R, Lee JY, Kaslow RA et al. Decrease of cytomegalovirus replication in human immunodeficiency virus-infected patients after treatment with highly active antiretroviral therapy. J Infect Dis 1999; 180: 847-9.
35. Kirk O, Pedersen C, Cozzi-Lepri A, Antunes F, Miller V, Gatell JM et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 2001; 98: 3406-12.
36. Gates AE, Kaplan LD. AIDS malignancies in the era of highly active antiretroviral therapy. Oncology 2002; 16: 657-65.
37. Berger JR, Major EO. Progressive muitifocal leukoencephalopathy. Semin Neurol 1999; 19: 193-200.
38. Gray F, Bélec L, Lescs MC, Chrétien F, Ciardi A, Hassine D et al. Varicella zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain 1994; 117: 987-99.
39. Chrétien F, Bélec L, Lescs MC, De Truchis P, Scaravilli F, Gray F. Infection du système nerveux central par le virus de la varicelle et du zona au cours du syndrome d'immunodéficience acquise. Arch Anat Cytol Pathol 1997; 45: 142-52.
40. Tan SV, Guiloff RJ, Scaravilli F, Klapper PE, Graham MC, Gazzard BG. Herpes simplex type 1 encephalitis in acquired immunodeficiency syndrome. Ann Neurol 1993; 34: 619-22.
41. Chrétien F, Bélec L, Wingerstman L, De Truchis P, Baudrimont M, Perronne C et al. Infection du système nerveux par le virus herpes simplex au cours du syndrome d'immunodéficience acquise. Arch Anat Cytol Pathol 1997; 45: 153-8.
42. Chrétien F, Bélec L, Hilton DA, Flament-Saillour M, Guillon F, Wingertsmann L et al. Herpes simplex type 1 encephalitis in acquired immunodeficiency syndrome Neuropathol Appl Neurobiol 1996; 22: 394-404.
43. Nebuloni M, Vago L, Boldorini R, Bonetto S, Costanzi G. VZV fulminant necrotizing encephalitis with concomitant EBV-related lymphoma and CMV ventriculitis: report of an AIDS case. J Neurovirol 1998; 4: 457-60.
44. Gray F, Bélec L, Keohane C, De Truchis P, Clair B, Durigon M et al. Zidovudine therapy and HIV encephalitis: a 10-year neuropathological survey. AIDS 1994; 8: 489-93.
45. Lesprit P, Chaline-Lehmann D, Authier FJ, Ponnelle T, Gray F, Levy Y. BK virus encephalitis in a patient with AIDS and lymphoma. AIDS 2001; 15: 1196-9.
46. Vallbracht A, Löhler J, Gossmann J, Gluck T, Petersen D, Gerth HJ et al. Disseminated BK virus type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol 1993; 143: 29-39.
47. Bratt G, Hammarin AL, Grandien M, Hedquist BG, Nennesmo I, Sundelin B et al. BK virus as a cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS 1999; 13: 1071-5.
48. Musher DM, Hamill RJ, Baughn RE. Effect of human immunodeficiency virus (HIV) infection in the course of syphilis and on the response to treatment. Ann Intern Med 1990; 113: 872-81.
49. Gray F, Alonso JM. Bacterial Infections of the Central Nervous System, In: Graham DI, Lantos PL, eds. Greenfield's Neuropathology 7th edition. London, New York, New Dehli: Arnold, 2002, Volume 2, chapter 3, pp 151-93.
50. Langford TD, Letendre SL, Marcotte TD, Ellis RJ, McCutchan JA, Grant I et al. Severe demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 2002; 16: 1019-29.
51. Cheng VCC, Yuen K-Y, Chan W-M, Wong SSY, Ma ESK, Chan RMT. Immunorestitution disease involving the innate and adaptative response. Clin Infect Dis 2000; 30: 882-92.
52. Foudraine NA, Hovenkamp E, Notermans DW, Meenhorst PL, Klein MR, Lange JM et al. Immunopathology as a result of highly active antiretroviral therapy in HIV-1 infected patients. AIDS 1999; 13: 177-84.
53. Jacobson MA, Zegans M, Pavan PR, O'Donnell JJ, Sattler F, Rao N et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997; 349: 1443-5.
54. Ingrand D, Gray F. Leucoencephalite multifocale progressive: aspects virologiques et neuropathologiques. Arch Anat Cytol Pathol 1997; 45: 127-34.
55. Miralles P, Berenguer J, Lacruz C, Cosin J, Lopez PC, Padilla B et al. Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. AIDS 2001; 15: 1900-2.
56. Scaravilli F, Lucas S, Gray F, Kuo L, Hall-Craggs MA, An SF, Miller R. The changing presentation of encephalitis in AIDS (Abstract). J Neuropathol Exp Neurol 2003; 62: 562.
57. Strittmatter C, Lang W, Wiestler OD, Kleihues P. The changing pattern of human immunodeficiency virus-associated cerebral toxoplasmosis: a study of 46 postmortem cases. Acta Neuropathol 1992; 83: 475-81.
58. Gray F, Chrétien F, Orlikowsky D, Carlier R. "Burnt out" varicella-zoster-virus (VZV) encephalitis in an AIDS patients treated by highly active antiRetroviral therapy (HAART) (Abstract). Neuropathol Appl Neurobiol 2003; 29: 189-90.
59. Gray F, Mohr M, Rozenberg F, Bélec L, Lescs MC, Doumon E et al. Varicella-zoster virus encephalitis in acquired immunodeficiency syndrome: report of 4 cases. Neuropathol Appl Neurobiol 1992; 18: 502-14.
60. Scaravilli F, Gray F. Opportunistic infections. In: Gray F, ed, Atlas of the Neuropathology of HIV Infection. Oxford, New York, Tokyo: Oxford University Press, 1993, pp 49-120.
61. Schmidbauer M, Budka H, Shah KV. Progressive multifocal leukoencephalopathy (PML) in AIDS and in the pre-AIDS era. A neuropathological comparison using immunocytochemistry and in situ DNA hybridisation for virus detection. Acta Neuropathol 1990; 80: 375-80.
62. Gray F, Keohane C. The Neuropathology of HIV Infection in the era of highly active antiRetroviral therapy (HAART). Brain Pathol 2003; 13: 79-83.
63. Lambotte O, Deiva K, Tardieu M. HIV-1 persistence, viral reservoir and the central nervous system at the HAART era. Brain Pathol 2003; 13: 95-103.
64. Authier FJ, Gherardi R. Involvement of the peripheral nerve in the HAART era. Brain Pathol 2003; 13: 223-8.
65. Kandanearatchi A, Williams B, Everall IP. Assessing the efficacy of highly active antiretroviral therapy in the brain. Brauin Pathol 2003; 13: 104-10.
66. Gea-Banacioche JC, Clifford Lane H. Immune reconstitution in HIV infection. AIDS 1999; 13: S25-S38.